货号:GS40548
Pimivalimab (JTX-4014) is a humanized, IgG4 monoclonal antibody developed as an immune checkpoint inhibitor for cancer immunotherapy. It is designed to specifically target and block the PD-1 (Programmed Death-1) receptor. Clinical trials have been conducted to evaluate its safety and efficacy, both as a monotherapy and in combination with other agents, for treating various advanced solid tumors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯